Long

BMY breakout

strength in drug names, up 20% after EPS another one that gap up on EPS. Looking for to top out at the 63 level a short term 5% move. Hope for the best prepare for the worst.

schmidtke_jake

Also on:

Related publications

NKTR going into earnings

by schmidtke_jake

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.